Fig. 4
From: Depleting TMED3 alleviates the development of endometrial carcinoma
TMED3 mediated EC cell phenotype via PI3K/AKT signaling pathway. A The expression levels of PI3K, p-PI3K, AKT and p-AKT in HEC-1-B and ishikawa cells in each cell group. B The comparisons in cellular ability of proliferation among four cell groups. C The comparisons in percentages of apoptotic cells among four cell groups. *P < 0.05, **P < 0.01, ***P < 0.001